These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 78910)
21. Comparison of mammary tumorigenesis between litters in relation to mammary tumor virus antigenic expression in the milk of C3H/He mice. Nagasawa H; Nakajima Y; Morimoto J; Imai S; Tsubura Y Life Sci; 1982 Jul; 31(1):83-8. PubMed ID: 6287151 [TBL] [Abstract][Full Text] [Related]
22. Autogenous antibodies against the murine mammary tumor virus in strains of mice with low incidences of mammary tumors. Michalides R; Wagenaar E; Nusse R J Natl Cancer Inst; 1979 Apr; 62(4):935-41. PubMed ID: 219283 [TBL] [Abstract][Full Text] [Related]
23. Dependence of initiation of an innocent bystander cytotoxicity reaction on the association of viral antigens and tumor cell membranes in mice. Lopez DM; Lopez PF; Parks WP; Paul RD J Natl Cancer Inst; 1986 May; 76(5):923-31. PubMed ID: 2871214 [TBL] [Abstract][Full Text] [Related]
24. Characterization of cytotoxic effector cells in the mouse mammary tumor system. Lane MA; Roubinian J; Slomich M; Trefts P; Blair PB J Immunol; 1975 Jan; 114(1 Pt 1):24-9. PubMed ID: 46242 [TBL] [Abstract][Full Text] [Related]
25. Mouse mammary tumor virus genome expression in chemical carcinogen-induced mammary tumors in low- and high-tumor-incidence mouse strains. Dusing-Swartz S; Medina D; Butel JS; Socher SH Proc Natl Acad Sci U S A; 1979 Oct; 76(10):5360-4. PubMed ID: 228289 [TBL] [Abstract][Full Text] [Related]
26. Antibodies to mouse mammary tumor virus-related antigen in sera of patients with breast carcinoma. Tomana M; Kajdos AH; Niedermeier W; Durkin WJ; Mestecky J Cancer; 1981 Jun; 47(11):2696-703. PubMed ID: 6266639 [TBL] [Abstract][Full Text] [Related]
27. Immunoelectron microscopic localization of mammary tumor virus (MTV) antigens in normal and cancerous mammary glands of mice. Tsubura A; Shikata N; Hilgers J; Zotter S; Tanaka H; Morii S Microbiol Immunol; 1987; 31(7):665-74. PubMed ID: 2830473 [TBL] [Abstract][Full Text] [Related]
28. C3H/HeN mammary tumor-bearing mice develop type-specific neutralizing antibodies and group-specific precipitating antibodies for the mouse mammary tumor virus. Massey R; Arthur LO; Long CW; Schochetman G J Virol; 1980 Jan; 33(1):123-8. PubMed ID: 6154146 [TBL] [Abstract][Full Text] [Related]
29. Immunologic methods for the identification of cell types. II. Expression of normal mouse mammary epithelial cell antigens in mammary neoplasia. Ceriani RL; Peterson JA; Abraham S J Natl Cancer Inst; 1978 Sep; 61(3):747-51. PubMed ID: 80454 [TBL] [Abstract][Full Text] [Related]
30. Kinetics of responses to tumor antigens and mouse mammary tumor virus in BALB/cCrgl and BALB/cfC3H mice. Lopez DM; Sigel MM; Charyulu VL J Natl Cancer Inst; 1981 Jan; 66(1):191-6. PubMed ID: 6256573 [TBL] [Abstract][Full Text] [Related]
31. Quantitative estimation of mouse mammary tumor virus (MTV) antigens by radioimmunoassay; Verstraeten AA; Van Nie R; Kwa HG; Hageman PC Int J Cancer; 1975 Feb; 15(2):270-81. PubMed ID: 47846 [TBL] [Abstract][Full Text] [Related]
32. Immunocytochemical distribution of mouse mammary tumor virus antigens in BALB/cfC3H mammary epithelium. St George JA; Cardiff RD; Young LJ; Faulkin LJ J Natl Cancer Inst; 1979 Sep; 63(3):813-20. PubMed ID: 224238 [TBL] [Abstract][Full Text] [Related]
33. Immunoelectron microscopic studies of antibodies in mouse sera directed against mouse mammary tumor virus. Miller MF; Dmochowski L; Bowen JM Cancer Res; 1977 Jul; 37(7 Pt 1):2086-91. PubMed ID: 193633 [TBL] [Abstract][Full Text] [Related]
34. Tissue culture studies of mouse mammary tumor cells and associated viruses. Owens RB; Hackett AJ J Natl Cancer Inst; 1972 Nov; 49(5):1321-32. PubMed ID: 4346536 [No Abstract] [Full Text] [Related]
35. Naturally occurring humoral immunity to murine mammary tumor virus (MuMTV) and MuMTV GP52 in mice with low mammary tumor incidence. Arthur LO; Fine DL Int J Cancer; 1978 Dec; 22(6):734-40. PubMed ID: 214408 [No Abstract] [Full Text] [Related]
36. Bioactivity of C3H and RIII mammary tumor viruses in virgin female BALB/c mice. Squartini F; Bistocchi M J Natl Cancer Inst; 1977 Jun; 58(6):1845-7. PubMed ID: 194047 [TBL] [Abstract][Full Text] [Related]
37. Enhanced immune reactivity to hepatoma 22a cells in MTV-infected compared with MTV-free C3H mice. Lavrovsky VA; Viksler VK Immunology; 1981 Dec; 44(4):671-6. PubMed ID: 6274791 [TBL] [Abstract][Full Text] [Related]
38. Detection of acquired provirus sequences in mammary tumors from low-expressor, low-risk mice. Altrock BW; Cardiff RD; Puma JP; Lund JK J Natl Cancer Inst; 1982 Jun; 68(6):1037-41. PubMed ID: 6283224 [TBL] [Abstract][Full Text] [Related]
39. Mouse mammary tumor virus associated antigens and superantigens--immuno-molecular correlates of neoplastic progression. Wei WZ; Gill RF; Wang H Semin Cancer Biol; 1993 Jun; 4(3):205-13. PubMed ID: 8391342 [TBL] [Abstract][Full Text] [Related]
40. Immunologic studies with mouse mammary tumor viruses: comparative studies with spontaneous mammary tumor cell vaccines from five inbred mouse strains. Girardi AJ; Dion AS; Holben JA J Natl Cancer Inst; 1985 Jan; 74(1):105-12. PubMed ID: 2982052 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]